The government, in its Draft Pharmaceutical Policy – 2017, had proposed several incentives to encourage local industries to take up the manufacture of bulk drugs. This included giving preference to the formulations produced from indigenously produced APIs in government procurements and taking them out of price control for five years.
The government had earlier said "it is examining the recommendations of the committee which has recommended establishment of mega parks for APIs with common facilities".
"We have moved a Cabinet note on the basis of Katoch committee recommendations and at present it is under discussion," fertiliser minister Ananth Kumar said on Wednesday.
Speaking to CNBC-TV18, Mukesh Naik, MD of NutraPlus told that Cadila, Wanbury, Sun Pharma and Alkem Labs are some of their major clients where the former three contribute 20 percent to the company‘s sales.